Skip to main content

Ardent Health, Inc. (ARDT) Stock Analysis

Range Bound setup

SellModerate Confidence

Healthcare · Medical Care Facilities

Earnings in 5 days (2026-05-05). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Sell if holding. At $9.42, A.R:R 1.2:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Leverage penalty (D/E 1.4): -0.5; Earnings in 5 days (event risk).

Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services,... Read more

$9.42+14.9% A.UpsideScore 5.2/10#18 of 27 Medical Care Facilities
Stop $8.76Target $10.82(analyst − 13%)A.R:R 1.3:1
Analyst target$12.44+32.0%11 analysts
$10.82our TP
$9.42price
$12.44mean
$15

Sell if holding. At $9.42, A.R:R 1.2:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Leverage penalty (D/E 1.4): -0.5; Earnings in 5 days (event risk). Chart setup: RSI 50 mid-range, Bollinger mid-band. Score 5.2/10, moderate confidence.

Passes 4/8 gates (clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and death cross (50MA < 200MA) and earnings proximity 5d<=7d. Suitability: aggressive.

Thesis

Rewards
Strong earnings beat streak (3/4)
Attractive valuation
Margin of safety: 33%
Risks
Leverage penalty (D/E 1.4): -0.5
Earnings in 5 days (event risk)
Negative momentum

Key Metrics

P/E (TTM)10.0
P/E (Fwd)8.3
Mkt Cap$1.4B
EV/EBITDA7.0
Profit Mgn2.1%
ROE14.4%
Rev Growth-0.1%
Beta
DividendNone
Rating analysts19

Quality Signals

Piotroski F7/9

Options Flow

P/C1.00neutral
IV111%elevated
Max Pain$25+165.4% vs spot

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

2 floor-breakers·1 ceiling hit

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Volume
0.0
Obv
1.0
Ma Position
3.0
Macd
3.7
Rsi
4.5
Volume distribution (falling OBV)Below 200-MA, MA slope -5.9%/30d — confirmed downtrend

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Growth Rank
1.2
Quality Rank
3.6
Value Rank
9.2
Attractive P/E vs peers
GatesMomentum 2.4<4.5A.R:R 1.2 < 1.5@spotDeath cross (50MA < 200MA)EARNINGS PROXIMITY 5d<=7dInsider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARRange BoundSuitability: Aggressive
RSI
50 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $8.30Resistance $10.34

Price Targets

$9
$11
A.Upside+14.9%
A.R:R1.3:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeCautious

Risk Alerts

! Momentum score 2.4/10 — below 4.5 minimum
! Reward/Risk 1.2:1 at current price — below 1.5:1 minimum
! Death cross — 50-day MA below 200-day MA

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-05-05 (5d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is ARDT stock a buy right now?

Sell if holding. At $9.42, A.R:R 1.2:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Leverage penalty (D/E 1.4): -0.5; Earnings in 5 days (event risk). Chart setup: RSI 50 mid-range, Bollinger mid-band. Prior stop was $8.76. Score 5.2/10, moderate confidence.

What is the ARDT stock price target?

Take-profit target: $10.82 (+14.9% upside). Prior stop was $8.76. Stop-loss: $8.76.

What are the risks of investing in ARDT?

Leverage penalty (D/E 1.4): -0.5; Earnings in 5 days (event risk); Negative momentum.

Is ARDT overvalued or undervalued?

Ardent Health, Inc. trades at a P/E of 10.0 (forward 8.3). TrendMatrix value score: 8.6/10. Verdict: Sell.

What do analysts say about ARDT?

19 analysts cover ARDT with a consensus score of 3.9/5. Average price target: $12.

What does Ardent Health, Inc. do?Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the...

Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. The company operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. Ardent Health, Inc. was formerly known as Ardent Health Partners, Inc. and changed its name to Ardent Health, Inc. in June 2025. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health, Inc. is a subsidiary of EGI-AM Investments, L.L.C.

Related stocks: AVAH (Aveanna Healthcare Holdings Inc) · UHS (Universal Health Services, Inc.) · ADUS (Addus HomeCare Corporation) · ASTH (Astrana Health Inc.) · CON (Concentra Group Holdings Parent)